Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women linked to higher sexual dysfunction risk.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

People with male pattern baldness are more likely to have metabolic syndrome.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Mesenchymal stem cell-derived exosomes significantly increase hair density and thickness in androgenic alopecia patients.

Uncombable hair syndrome causes frizzy hair and can affect the nervous system, eyes, and ears, often co-occurring with other hair, skin, nail, and teeth conditions, and is linked to three specific gene mutations.

Using your own platelet-rich plasma (PRP) can effectively treat hair loss, increasing hair density and width with no side effects.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

New methods improve how we test hair growth treatments, but challenges like slow hair changes and high costs remain.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Finasteride shows promise for female hair loss, but more research needed.

Different factors help diagnose and treat hair loss accurately.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Non-obese women with hair loss have higher heart disease risk.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.